Brian Cameron
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 10
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 2
- T-cell and B-cell Immunology 2
- Oncology 6
- CAR-T cell therapy research 5
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Sharon J. Peacock (2 shared papers)Timothy J. Foster (2 shared papers)Anthony Robert Berendt (1 shared paper)Bent K. Jakobsen (6 shared papers)Tara Mahon (4 shared papers)Laura Douglas (1 shared paper)Ruth K. Moysey (4 shared papers)Marco A. Purbhoo (3 shared papers)
- Journals
- Infection and Immunity (2 papers)Nature Medicine (2 papers)Journal of Clinical Investigation (1 paper)Science Translational Medicine (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
Brian Cameron
14 papers receiving 1.6k citations
Brian Cameron's Hit Papers
Peers
Comparison fields: 5 of 63
- Immunology 727
- Oncology 746
- Virology 97
- Radiology, Nuclear Medicine and Imaging 243
- Infectious Diseases 177
Countries citing papers authored by Brian Cameron
This map shows the geographic impact of Brian Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Cameron more than expected).
Fields of papers citing papers by Brian Cameron
This network shows the impact of papers produced by Brian Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Cameron. The network helps show where Brian Cameron may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Cameron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells Hit paper breakdown → | 2013 | 586 |
| 2 | 2012 | 278 | |
| 3 | 2008 | 207 | |
| 4 | 1999 | 202 | |
| 5 | 2006 | 93 | |
| 6 | 2006 | 86 | |
| 7 | 2018 | 71 | |
| 8 | 2020 | 70 | |
| 9 | 1996 | 42 | |
| 10 | 2007 | 39 | |
| 11 | 2002 | 19 | |
| 12 | Monoclonal TCR-redirected tumor cell killing. Nat Med | 2012 | 14 |
| 13 | 2010 | 8 | |
| 14 | 2015 | 3 |
About Brian Cameron
Brian Cameron is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Virology, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers), T-cell and B-cell Immunology (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers) and Antifungal resistance and susceptibility (1 paper). The work is most often cited by research in Immunology (727 citations), Oncology (746 citations), Virology (97 citations), Radiology, Nuclear Medicine and Imaging (243 citations) and Infectious Diseases (177 citations). Brian Cameron has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Sharon J. Peacock, Timothy J. Foster, Anthony Robert Berendt, Bent K. Jakobsen, Tara Mahon, Laura Douglas, Ruth K. Moysey, Marco A. Purbhoo, Deborah H. Sutton and Steven Mark Dunn. Their work appears in journals such as Infection and Immunity, Nature Medicine, Journal of Clinical Investigation, Science Translational Medicine and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.